Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Revenue Recognition (Details)	6 Months Ended
Jun. 30, 2024
Janssen Pharmaceuticals Inc \| Collaborative Arrangement [Member]
Revenue Recognition, Milestone Method [Line Items]
Percentage of incurred R&D costs to be reimbursed by third parties	100

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

No definition available.

Name:	us-gaap_RevenueRecognitionMilestoneMethodLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration